Literature DB >> 25194894

Usefulness of the HKLC vs. the BCLC staging system in a European HCC cohort.

Xavier Adhoute1, Guillaume Penaranda2, Jean-Pierre Bronowicki3, Jean-Luc Raoul4.   

Abstract

Mesh：

Year:  2014        PMID： 25194894     DOI： 10.1016/j.jhep.2014.08.035

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  18 in total

Review 1.  Recommendations for the use of chemoembolization in patients with hepatocellular carcinoma: Usefulness of scoring system?

Authors:  Xavier Adhoute; Guillaume Penaranda; Paul Castellani; Herve Perrier; Marc Bourliere
Journal:  World J Hepatol       Date:  2015-03-27

Review 2.  Overview of Staging Systems for Hepatocellular Carcinoma and Implications for Interventional Radiology.

Authors:  Jan Hansmann; Charles E Ray
Journal:  Semin Intervent Radiol       Date:  2017-06-01       Impact factor: 1.513

3.  Validation of the Hong Kong Liver Cancer Staging System in Determining Prognosis of the North American Patients Following Intra-arterial Therapy.

Authors:  Jae Ho Sohn; Rafael Duran; Yan Zhao; Florian Fleckenstein; Julius Chapiro; Sonia Sahu; Rüdiger E Schernthaner; Tianchen Qian; Howard Lee; Li Zhao; James Hamilton; Constantine Frangakis; MingDe Lin; Riad Salem; Jean-Francois Geschwind
Journal:  Clin Gastroenterol Hepatol       Date:  2016-11-12       Impact factor: 11.382

4.  Radiomics score: a potential prognostic imaging feature for postoperative survival of solitary HCC patients.

Authors:  Bo-Hao Zheng; Long-Zi Liu; Zhi-Zhi Zhang; Jie-Yi Shi; Liang-Qing Dong; Ling-Yu Tian; Zhen-Bin Ding; Yuan Ji; Sheng-Xiang Rao; Jian Zhou; Jia Fan; Xiao-Ying Wang; Qiang Gao
Journal:  BMC Cancer       Date:  2018-11-21       Impact factor: 4.430

5.  The Prognostic Ability of Major Hepatocellular Carcinoma Staging Systems Is Improved by Including a Treatment Variable.

Authors:  Michael C Wallace; Matthew Knuiman; Yi Huang; George Garas; Leon A Adams; Gerry MacQuillan; David B Preen; Gary P Jeffrey
Journal:  Dig Dis Sci       Date:  2018-05-28       Impact factor: 3.199

6.  HKLC Triages More Hepatocellular Carcinoma Patients to Curative Therapies Compared to BCLC and Is Associated with Better Survival.

Authors:  Michael C Wallace; Yi Huang; David B Preen; George Garas; Leon A Adams; Gerry MacQuillan; Jonathan Tibballs; John Ferguson; Shaun Samuelson; Gary P Jeffrey
Journal:  Dig Dis Sci       Date:  2017-05-25       Impact factor: 3.199

7.  The Combination of Age, International Standardized Ratio, Albumin and γ-Glutamyl Transpeptidase (AIAG), Tumor Size and Alpha Fetoprotein (AFP) Stage as the Prognostic Model for Hepatitis B-Related Hepatocellular Carcinoma.

Authors:  Shuangchi Liu; Zhiduan Xu; Zhuling Fang; Dengyong Zhang; Zhongqiang Qin; Longfei Fan; Jiakang Duan; Hongxiang Yin; Yigang Zhang; Qing Pang; Yi Tan
Journal:  Int J Gen Med       Date:  2021-08-10

Review 8.  Usefulness of staging systems and prognostic scores for hepatocellular carcinoma treatments.

Authors:  Xavier Adhoute; Guillaume Penaranda; Jean Luc Raoul; Patrice Le Treut; Emilie Bollon; Jean Hardwigsen; Paul Castellani; Hervé Perrier; Marc Bourlière
Journal:  World J Hepatol       Date:  2016-06-18

Review 9.  Patient Selection for Transarterial Chemoembolization in Hepatocellular Carcinoma: Importance of Benefit/Risk Assessment.

Authors:  Fabio Piscaglia; Sadahisa Ogasawara
Journal:  Liver Cancer       Date:  2018-01-12       Impact factor: 11.740

10.  Hong Kong Liver Cancer Staging System Is Associated With Better Performance for Hepatocellular Carcinoma: Special Emphasis on Viral Etiology.

Authors:  Po-Hong Liu; Chia-Yang Hsu; Yun-Hsuan Lee; Chien-Wei Su; Cheng-Yuan Hsia; Yi-Hsiang Huang; Yi-You Chiou; Han-Chieh Lin; Teh-Ia Huo
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.